CENTENE CORPORATION REPORTS THIRD QUARTER 2026 RESULTS

What happened

Centene reported third quarter 2026 results with a GAAP diluted loss per share of $(0.14) and adjusted diluted earnings per share of $0.58. The health benefits ratio was 92.7%, which means medical costs as a share of premium revenue.

Confirmed

Global impact / market context

Centene raised its 2026 adjusted diluted EPS guidance by $0.40 and improved its full-year health benefits ratio expectation, suggesting medical costs are more controlled. That matters because a lower health benefits ratio leaves more of each premium dollar as profit, supporting earnings and cash available.

Analyst inference

Centene reduced debt by $1.1 billion since June 30, 2026, including fully redeeming 2027 Senior Notes in October, which lowers future interest costs and borrowed money. However, total cash flow used in operations was negative in the quarter, a strain investors may weigh against improved guidance.

Analyst inference

What to watch

1. Centene's full year 2026 health benefits ratio mid-point expectation improved by 15 basis points to 90.75%, which means medical costs as a share of premium revenue, a figure investors can compare with future quarterly results. Confirmed
2. Management aims to keep Medicaid and Marketplace results on track while sustaining the Medicare-driven improvement, so watch whether these segments support the raised adjusted diluted EPS guidance greater than $5.20. Proposed
3. Negative total cash flow from operations contrasts with improved earnings guidance; watch whether operating cash flow recovers, since weak cash generation can limit debt reduction and capital spending. Analyst inference

Evidence

• Original source link unavailable